Parsemus Foundation is ready to launch clinical trials on Vasalgel, a contraceptive gel for men, according to a MSN report. Human trials are expected to begin in 2015, with a target of having the product in the market by 2017, 57 years after the U.S. Food and Drug Administration first approved The Pill for contraceptive use and changed birth control options forever.
According to Parsemus, Vasalgel…
